GE HealthCare Unveils Enhancements to Venue Point-of-Care Ultrasound Systems
New enhancements for the Venue POCUS devices include automated labeling of anatomical landmarks with Nerveblox to facilitate 12 common peripheral nerve blocks and contrast-enhanced ultrasound geared to abdominal injury assessments.
Current Perspectives on Prostate Cancer and Emerging Theranostic Agents, Part 2
In the second part of a recent interview, Emmanuel S. Antonarakis, M.D. discusses PSMA PET agents in current trials and cell surface proteins that may offer targeting utility in prostate cancer imaging beyond PSMA.
Can the Emerging InteleHeart Platform Facilitate Improved Efficiency with Cardiology and Radiology?
Through enhanced data interoperability and access to patient histories, the cloud-based InteleHeart may facilitate better communication and workflow efficiencies for radiologists and cardiologists.
Current Insights on Interoperability, Enterprise Imaging and AI Integration in Radiology
In a recent interview, Morris Panner offered his perspective on cultural hurdles to interoperability in health care, emerging trends with enterprise imaging and an answer first approach to integrating AI in radiology.
FDA Clears CT-Based AI For Detection of Mitral Annular Calcification
The AI-powered Bunkerhill MAC software reportedly facilitates chest CT detection and quantification of mitral annular calcification, which has been linked to higher cardiovascular risk and related mortality.
A Closer Look at the Mammo Enhance Heart Program: An Interview with Arthy Saravanan, MD
In a recent interview, Arthy Saravanan, M.D., discussed the recent launch of the Mammo Enhance Heart program from Radiology Partners and its potential impact in facilitating dual screening for breast cancer and cardiovascular risk.
Nine Takeaways from New Consensus on Abdominal Photon-Counting CT Protocols in Adults
Based on survey findings and subsequent voting from radiologists at nine facilities, the Society of Abdominal Radiology has issued new consensus recommendations on the use of adult abdominal photon-counting CT.
Current Perspectives on Prostate Cancer and Emerging Theranostic Agents, Part 1
In a recent interview, Emmanuel S. Antonarakis, M.D. discussed contributing factors to the recent American Cancer Society report about rising prostate cancer incidence and offered insights about the potential role of the radioligand agent 177Lu-PSMA-I&T for patients with mCRPC.
FDA Grants De Novo Approval for Cryoablation Treatment of Breast Cancer
In a multicenter trial, researchers found 96.3 percent of women with low-risk, early-stage breast cancer had no local recurrence after being treated with a combination of ProSense cryoablation and hormone therapy.